Clinical trial / 2012
Preoperative green tea extract did not significantly alter prostate cancer biomarkers
A randomized trial tested daily polyphenon E containing 800 mg epigallocatechin gallate against placebo for 3 to 6 weeks before radical prostatectomy in prostate cancer patients. Polyphenol accumulation in surgical prostate tissue remained low or undetectable following supplementation. Treatment produced favorable but non-significant shifts in prostate-specific antigen, insulin-like growth factor axis markers, leukocyte DNA damage, Gleason scores, cell proliferation, apoptosis, and angiogenesis.
- Study type
- Randomized controlled trial
- Who was studied
- Men with prostate cancer awaiting radical prostatectomy
- What was measured
- Tissue polyphenol levels and systemic and prostate tissue biomarkers
THE PAPER
Randomized, double-blind, placebo-controlled trial of polyphenon E in prostate cancer patients before prostatectomy: evaluation of potential chemopreventive activities.
Nguyen MM, Ahmann FR, Nagle RB, Hsu CH, Tangrea JA, Parnes HL, Sokoloff MH, Gretzer MB, Chow HH. Cancer Prev Res (Phila), 2012.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.